Entry Point Capital, LLC Ideaya Biosciences, Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 4,392 shares of IDYA stock, worth $129,388. This represents 0.23% of its overall portfolio holdings.
Number of Shares
4,392Holding current value
$129,388% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding IDYA
# of Institutions
210Shares Held
73.8MCall Options Held
21.5KPut Options Held
20.3K-
Black Rock Inc. New York, NY6.81MShares$201 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.86MShares$143 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.27MShares$126 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X04.08MShares$120 Million0.08% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.74MShares$110 Million0.02% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.42B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...